AAAAAA

   
Results: 1-8 |
Results: 8
AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES
Authors: LESAGE AS WOUTERS R VANGOMPEL P HEYLEN L VANHOENACKER P HAEGEMAN G LUYTEN WHML LEYSEN JE
Citation: As. Lesage et al., AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES, British Journal of Pharmacology, 123(8), 1998, pp. 1655-1665
RISPERIDONE COMPARED WITH NEW AND REFERENCE ANTIPSYCHOTIC-DRUGS - IN-VITRO AND IN-VIVO RECEPTOR-BINDING
Authors: SCHOTTE A JANSSEN PFM GOMMEREN W LUYTEN WHML VANGOMPEL P LESAGE AS DELOORE K LEYSEN JE
Citation: A. Schotte et al., RISPERIDONE COMPARED WITH NEW AND REFERENCE ANTIPSYCHOTIC-DRUGS - IN-VITRO AND IN-VIVO RECEPTOR-BINDING, Psychopharmacology, 124(1-2), 1996, pp. 57-73
ALNIDITAN, A NEW 5-HYDROXYTRYPTAMINE(1D) AGONIST AND MIGRAINE-ABORTIVE AGENT - LIGAND-BINDING PROPERTIES OF HUMAN 5-HYDROXYTRYPTAMINE(1D-ALPHA), HUMAN 5-HYDROXYTRYPTAMINE(1D-BETA), AND CALF 5-HYDROXYTRYPTAMINE(1D) RECEPTORS INVESTIGATED WITH [H-3] 5-HYDROXYTRYPTAMINE AND [H-3] ALNIDITAN
Authors: LEYSEN JE GOMMEREN W HEYLEN L LUYTEN WHML VANDEWEYER I VANHOENACKER P HAEGEMAN G SCHOTTE A VANGOMPEL P WOUTERS R LESAGE AS
Citation: Je. Leysen et al., ALNIDITAN, A NEW 5-HYDROXYTRYPTAMINE(1D) AGONIST AND MIGRAINE-ABORTIVE AGENT - LIGAND-BINDING PROPERTIES OF HUMAN 5-HYDROXYTRYPTAMINE(1D-ALPHA), HUMAN 5-HYDROXYTRYPTAMINE(1D-BETA), AND CALF 5-HYDROXYTRYPTAMINE(1D) RECEPTORS INVESTIGATED WITH [H-3] 5-HYDROXYTRYPTAMINE AND [H-3] ALNIDITAN, Molecular pharmacology, 50(6), 1996, pp. 1567-1580
LUBELUZOLE, A NOVEL LONG-TERM NEUROPROTECTANT, INHIBITS THE GLUTAMATE-ACTIVATED NITRIC-OXIDE SYNTHASE PATHWAY
Authors: LESAGE AS PEETERS L LEYSEN JE
Citation: As. Lesage et al., LUBELUZOLE, A NOVEL LONG-TERM NEUROPROTECTANT, INHIBITS THE GLUTAMATE-ACTIVATED NITRIC-OXIDE SYNTHASE PATHWAY, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 759-766
EVALUATION OF SEVERAL IN-VITRO AND IN-VIVO MODELS FOR OXIDATIVE STRESS
Authors: LESAGE AS VANASSOUW H VANGOMPEL P CIK M LEYSEN J
Citation: As. Lesage et al., EVALUATION OF SEVERAL IN-VITRO AND IN-VIVO MODELS FOR OXIDATIVE STRESS, Journal of neurochemistry, 66, 1996, pp. 33-33
NEUROPROTECTIVE SIGMA-LIGANDS INTERFERE WITH THE GLUTAMATE-ACTIVATED NOS PATHWAY IN HIPPOCAMPAL CELL-CULTURE
Authors: LESAGE AS DELOORE KL PEETERS L LEYSEN JE
Citation: As. Lesage et al., NEUROPROTECTIVE SIGMA-LIGANDS INTERFERE WITH THE GLUTAMATE-ACTIVATED NOS PATHWAY IN HIPPOCAMPAL CELL-CULTURE, Synapse, 20(2), 1995, pp. 156-164
VARIOUS SIGMA-LIGANDS EXERT LONG-TERM PROTECTION AGAINST GLUTAMATE TOXICITY IN PRIMARY HIPPOCAMPAL-NEURONS - APPARENT NON INVOLVEMENT OF IDENTIFIED SIGMA-2 SITES
Authors: DELOORE KL LESAGE AS PEETERS L LEYSEN JE
Citation: Kl. Deloore et al., VARIOUS SIGMA-LIGANDS EXERT LONG-TERM PROTECTION AGAINST GLUTAMATE TOXICITY IN PRIMARY HIPPOCAMPAL-NEURONS - APPARENT NON INVOLVEMENT OF IDENTIFIED SIGMA-2 SITES, Neuroscience research communications, 14(1), 1994, pp. 43-51
THE SIGMA SITE BINDING-ACTIVITY OF DRUGS AND THEIR PROTECTIVE ACTION AGAINST GLUTAMATE TOXICITY IN HIPPOCAMPAL-NEURONS
Authors: DELOORE KL LESAGE AS LEYSEN JE
Citation: Kl. Deloore et al., THE SIGMA SITE BINDING-ACTIVITY OF DRUGS AND THEIR PROTECTIVE ACTION AGAINST GLUTAMATE TOXICITY IN HIPPOCAMPAL-NEURONS, Journal of neurochemistry, 61, 1993, pp. 190000138-190000138
Risultati: 1-8 |